Related references
Note: Only part of the references are listed.Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
Nathalie A. Johnson et al.
BLOOD (2009)
Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma
Yuko Nomura et al.
CANCER SCIENCE (2008)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Michael Hummel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior
RE McClure et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
N Mounier et al.
BLOOD (2003)
The distinction between Burkitt lymphoma and diffuse large B-cell lymphoma with c-Myc rearrangement
N Nakamura et al.
MODERN PATHOLOGY (2002)
bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements
G Papakonstantinou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
